Loading
Life sciences · Journal article
Drug Delivery · November 4, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Sepsis, a life-threatening organ dysfunction from a dysregulated infection response, remains a high-mortality global health burden characterized by the systemic overproduction of pro-inflammatory mediators and reactive oxygen and nitrogen species. Timely anti-infective/anti-inflammatory interventions in the early onset window drastically improve sepsis prognosis, yet current therapeutic efficacy remains severely constrained by the global antibiotic resistance crisis. As a two-dimensional nanomaterial, Ti3C2Tx MXene displays potent intrinsic antimicrobial and anti-inflammatory activities. We herein engineer a neutrophil membrane-coated Ti3C2Tx nanoplatform (NM@Ti3C2Tx NPs) for targeted sepsis therapy. Experimental validation confirms this formulation mitigates sepsis-triggered oxidative stress injury via synergistic antioxidant pathways, with favorable colloidal stability and confirmed in vitro biocompatibility. In CLP-induced murine sepsis models, it attenuates systemic pro-inflammatory cascades, alleviates hypothermia and multi-organ damage, and improves survival. Collectively, this multifunctional platform integrating targeted antibacterial action and oxidative stress modulation presents a promising candidate for sepsis translational therapy.